Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Centers for ...

Some positive news is finally coming out of this beaten down healthcare stock. The post Why are Telix shares rocketing 22% ...

A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to research published in the ...

American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...

American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...

Plasma p-tau217 testing can help detect preclinical Alzheimer disease in cognitively unimpaired adults. Using it as a ...

Adding an indication for prostate cancer diagnosis has the potential to significantly expand the U.S. market for Telix’s twin commercial PSMA-PET imaging agents by approximately 800,000 scans 7.

Essentia Health launches its new amyloid PET scan tool for early Alzheimer's detection and diagnosis, the first in the Northland.

SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration ...

Note: The above video shows the top headlines from the morning of September 2, 2025. LUBBOCK, Texas— Covenant Medical Group is bringing a cutting-edge advancement in cardiac imaging to West Texas and ...

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target action date of March 2026. The US FDA has accepted a New Drug Application ...